Clinical Trial Results: A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight [Phase 2]

View source ↗

Summary

Phase 2 trial results for LY3841136 versus placebo in adults with obesity or overweight have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• LY3841136

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 2 | Status: COMPLETED | Results posted: 2026-06-24